Literature DB >> 12213477

Inhibition of inosine monophosphate dehydrogenase (IMPDH) by the antiviral compound, 2-vinylinosine monophosphate.

Suresh Pal1, Bindu Bera, Vasu Nair.   

Abstract

A new enzyme-mediated synthesis of 2-vinylinosine, a compound with broad-spectrum RNA antiviral activity, is described. In order to understand the mechanism of action of this compound, we synthesized its monophosphate and investigated the behavior of that compound toward the enzyme, inosine monophosphate dehydrogenase (IMPDH), a key enzyme involved in the biosynthesis of nucleotides. 2-Vinylinosine monophosphate is a potent inhibitor of IMPDH with a K(i) of 3.98 microM (k(inact)=2.94 x 10(-2) s(-1)). The antiviral activity of 2-vinylinosine may be explained by its cellular conversion to the monophosphate through the sequential action of PNP and HGPRT and subsequent inhibition of IMPDH by the cellularly produced 2-vinylinosine 5'-monophosphate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213477     DOI: 10.1016/s0968-0896(02)00247-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Base-functionalized carbocyclic nucleosides: design, synthesis, and mechanism of antiviral activity.

Authors:  Vasu Nair; Fan Zhang; Xiaohui Ma; Eric Bonsu
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

3.  Synthesis of a novel carbocyclic analog of bredinin.

Authors:  Vasu Nair; Fan Zhang
Journal:  Molecules       Date:  2013-09-17       Impact factor: 4.411

4.  Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.

Authors:  Albertus Eka Yudistira Sarwono; Shinya Mitsuhashi; Mohammad Hazzaz Bin Kabir; Kengo Shigetomi; Tadashi Okada; Fumina Ohsaka; Satoko Otsuguro; Katsumi Maenaka; Makoto Igarashi; Kentaro Kato; Makoto Ubukata
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.